Insulin-like growth factor-1 (IGF-1) empowering tendon regenerative therapies
Frontiers in Bioengineering and Biotechnology · 27.03.2025 · 13
DOI: 10.3389/fbioe.2025.1492811 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 27.03.2025. Verfasst von Mingming Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Police Basic Skills Teaching Department, Sichuan Police College, Luzhou, Sichuan, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tendon injury is one of the most common musculoskeletal disorders that severely affect patients’ daily lives. Unfortunately, naturally healed tendons exhibit poor quality, as they have very limited regenerative ability. Recently, therapeutic strategies involving the administration of growth factors have been advocated to enhance tendon regenerative healing. Growth factors are peptide-signaling molecules that elicit biological functions such as cell proliferation, migration, and differentiation by acting through a complex organization of cell surface receptors and activating intracellular signaling pathways. Insulin-like growth factor-1(IGF-1) represents one such factor that has shown promising effects for enhancing tendon regenerative healing in vitro and animal models. However, it is disappointing that IGF-1 has not been shown to play a very significant role in promoting tendon healing in clinical trials, which could reflect our poor understanding of the molecular mechanisms by which IGF-1 is involved in promoting tendon regenerative healing. Therefore, in this review, we summarized the roles and mechanisms of IGF-1 for enhancing tendon regenerative healing. Nevertheless, much work is still needed to optimize its effectiveness.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Police Basic Skills Teaching Department, Sichuan Police College, Luzhou, Sichuan, China.
- School of Physical Education, Southwest Medical University, Luzhou, Sichuan, China.
- The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Zitieren
APA
Wang, M., Zhang, J., Li, H., Li, Y., & Li, Z. (2025). Insulin-like growth factor-1 (IGF-1) empowering tendon regenerative therapies. Frontiers in Bioengineering and Biotechnology, 13. https://doi.org/10.3389/fbioe.2025.1492811
Vancouver
Wang M, Zhang J, Li H, Li Y, Li Z. Insulin-like growth factor-1 (IGF-1) empowering tendon regenerative therapies. Frontiers in Bioengineering and Biotechnology. 2025;13. doi:10.3389/fbioe.2025.1492811
BibTeX
@article{Wang2025,
author = {Wang, Mingming and Zhang, Jiayuan and Li, Hanyue and Li, Yini and Li, Zhigang},
title = {Insulin-like growth factor-1 (IGF-1) empowering tendon regenerative therapies},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2025},
volume = {13},
doi = {10.3389/fbioe.2025.1492811}
}
EUVIMED